Editorial: Identification of effective biomarkers for diagnosis and treatment of chronic kidney disease: integrating bioinformatics and pharmacological approaches by Swayam Prakash Srivastava, Keizo Kanasaki

Get full text

The Relevance of the Renin-Angiotensin System in the Development of Drugs to Combat Preeclampsia by Norikazu Ueki, Satoru Takeda, Daisuke Koya, Keizo Kanasaki

Get full text

Empagliflozin reduces liver fibrosis by restoring catechol-O-methyltransferase activity associated with magnesium levels by Yoshihiro Hayashi, Emi Kawakita, Naoki Kumashiro, Hiroshi Iijima, Daisuke Koya, Keizo Kanasaki

Get full text

Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent m... by Daisuke Koya, Mizue Fujii, Munehiro Kitada, Shin-ichi Tsuda, Kazunori Konishi, Ai Takeda-Watanabe, Keizo Kanasaki, Makoto Nishizawa, Atsushi Nakagawa

Get full text

The PKM2 activator TEPP‐46 suppresses cellular senescence in hydrogen peroxide‐induced proximal tubular cells and kidney fibrosis in CD‐1db/db mice by Shin‐ichiro Ishihara, Md. Imrul Kayes, Hirofumi Makino, Hiroaki Matsuda, Asako Kumagai, Yoshihiro Hayashi, Sara Amelia Ferdaus, Emi Kawakita, Daisuke Koya, Keizo Kanasaki

Get full text

Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study) by Daisuke Tsuriya, Kazuo Kobayashi, Kei Takeshita, Takuya Hashimoto, Moritsugu Kimura, Yoshimi Muta, Hisashi Yokomizo, Yuichi Takashi, Shunichiro Tsukamoto, Kouichi Tamura, Keizo Kanasaki, Daiji Kawanami, Masao Toyoda

Get full text